Iodine-125 seed implants for low risk prostate cancer: Disease control and opportunities for salvage

被引：0
|
作者：
Morton, G.
Loblaw, D. A.
Choo, R.
机构：
[1] Univ Toronto, Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[2] Mayo Clin, Rochester, MN USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 80卷
关键词：
D O I：
10.1016/S0167-8140(06)80885-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
144
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [21] Permanent brachytherapy of prostate cancer with iodine-125 -: Quality of life and local control
    Messer, PM
    Gottfried, HW
    Alfia, H
    Blumstein, NM
    Schneider, E
    Röttinger, EM
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 53 - 53
  • [22] Permanent brachytherapy of prostate cancer with iodine-125 -: Quality of life and local control
    Niewald, M
    Licht, N
    Loch, T
    Fleckenstein, J
    Wisser, L
    Rübe, C
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 53 - 53
  • [23] Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)
    Tanaka, Nobumichi
    Yorozu, Atsunori
    Kikuchi, Takashi
    Higashide, Satoshi
    Kojima, Shinsuke
    Ohashi, Toshio
    Katayama, Norihisa
    Nakamura, Katsumasa
    Saito, Shiro
    Dokiya, Takushi
    Fukushima, Masanori
    BRACHYTHERAPY, 2019, 18 (04) : 484 - 492
  • [24] A prediction model for biochemical failure after salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Van de Pol, S.
    Westendorp, H.
    Maenhout, M.
    Kattevilder, R.
    Verkooijen, H. M.
    Van Rossum, P. S. N.
    Ahmed, H. U.
    Shah, T.
    Emberton, M.
    Van Vulpen, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S28 - S29
  • [25] Rectal dose constraints for total and focal salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Westendorp, H.
    Kattevilder, R.
    Van de Pol, S. M.
    Maenhout, M.
    Van Vulpen, M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S64 - S65
  • [26] Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed
    Yamaguchi, Takahiro
    Matsuo, Masayuki
    Mori, Takayuki
    Noda, Yoshifumi
    Makita, Chiyoko
    Hyodo, Fuminori
    Iinuma, Koji
    Nakano, Masahiro
    Koie, Takuya
    Tanaka, Hidekazu
    CURRENT ONCOLOGY, 2023, 30 (04) : 4060 - 4066
  • [27] Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer
    Takamoto, Atsushi
    Tanimoto, Ryuta
    Bekku, Kensuke
    Araki, Motoo
    Sadahira, Takuya
    Wada, Koichiro
    Ebara, Shin
    Katayama, Norihisa
    Yanai, Hiroyuki
    Nasu, Yasutomo
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 507 - 512
  • [28] Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
    Simon Zuber
    Susan Weiß
    Dieter Baaske
    Michael Schöpe
    Simon Stevens
    Stephan Bodis
    Daniel R Zwahlen
    Radiation Oncology, 10
  • [29] Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
    Zuber, Simon
    Weiss, Susan
    Baaske, Dieter
    Schoepe, Michael
    Stevens, Simon
    Bodis, Stephan
    Zwahlen, Daniel R.
    RADIATION ONCOLOGY, 2015, 10
  • [30] Permanent low-activity iodine-125 implants for cerebral metastases
    Schulder, M
    Black, PM
    Shrieve, DC
    Alexander, E
    Loeffler, JS
    JOURNAL OF NEURO-ONCOLOGY, 1997, 33 (03) : 213 - 221
12345